This foundational paper describes familial hypercholesterolemia as a genetic defect in the LDL receptor leading to severe hypercholesterolemia and premature coronary heart disease.
Answers are grounded in this paper and cite their sources.
Informs recognition of autosomal-dominant hypercholesterolemia; leaves open therapeutic implications in the statin era.
FAMILIAL hypercholesterolemia, an example of a single-gene disorder that produces both hypercholesterolemia and atherosclerosis in man,1 2 3 is characterized by four cardinal features: hypercholesterolemia resulting from an elevated plasma concentration of low-density lipoprotein; tendon xanthomas; premature coronary heart disease; and autosomal-dominant inheritance. In patients who have inherited a single copy of the gene for familial hypercholesterolemia, the plasma cholesterol level is about 300 to 500 mg per 100 ml from birth, but symptoms do not develop until the third to the sixth decade, when tendon xanthomas and coronary heart disease appear. In patients who have inherited two copies of the gene, . . .
No takes yet. Share an insight, caveat, or question.
A 1976 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: